CARY STREET PARTNERS FINANCIAL LLC
Position in BSX — Boston Scientific Corp
CIK 1475045
RICHMOND, VA
Position in BSX
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,070,926
-$277,885 QoQ
Shares Held
25,092
+16.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#675
of 1,468 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 56%
Shared 0%
None 44%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS FINANCIAL LLC holds $20,874,572 across 9 Medical Devices names. BSX ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
112,940 | $8,835,295 | |
| 2 | ABT |
Abbott Laboratories
|
44,828 | $4,067,691 | |
| 3 | SYK |
Stryker Corp
|
9,767 | $3,075,041 | |
| 4 | HAE |
Haemonetics Corp
|
26,664 | $1,999,800 | |
| 5 | BSX |
Boston Scientific Corp
This page
|
25,092 | $1,070,926 | |
| 6 | EW |
Edwards Lifesciences Corp
|
10,034 | $907,675 | |
| 7 | SNN |
Smith & Nephew PLC
|
23,125 | $666,231 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
3,475 | $222,434 |
All Filings in BSX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,070,926 | 25,092 | Shares | Defined | 2026-07-17 | |
| 2026-03-31 | $1,348,811 | 21,495 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $1,994,149 | 20,914 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,788,093 | 18,315 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $2,010,500 | 18,718 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,653,018 | 16,386 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,496,288 | 16,752 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||